Funded startups/Psy Therapeutics, Inc.

Psy Therapeutics, Inc.

SEC filing

Pharmaceuticals · Boston, MA

Form D on EDGAR

Amount raised$6.8Msold at filing

Total offering$20.4M$13.6M still open

Investors in the raise23count reported to the SEC

FiledSep 12, 2025first sale Dec 23, 2021

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

David S. BarlowExecutive Officer, Director

Paul F. MurphyDirector

Alan S. CrossDirector

William F. WagnerExecutive Officer

Jerry F. RosenbaumDirector

Daniel S. Weiss PickDirector

Jeff S. TrodermanExecutive Officer

Executive officers, directors and promoters as listed on the Form D.